We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Assayed Controls Introduced for HIV and Hepatitis Testing

By LabMedica International staff writers
Posted on 23 Dec 2009
New assayed controls, which include analytes for human immunodeficiency virus (HIV) and hepatitis testing, have been launched.

The Assayed Virotrol I controls are prepared from human serum and are analyzed in the same manner as patient samples. The ready-to-use liquid formulation of the controls eliminates potential reconstitution variability. Routine use of Assayed Virotrol I controls provides laboratories with the ability to monitor the performance of their test procedures and assure quality on an ongoing basis. Values for many of the popular test systems are provided with each lot of Assayed Virotrol I.

Bio-Rad (Hercules, CA, USA) introduced the assayed Virotrol I controls for HIV and hepatitis testing. Assayed Virotrol I controls were designed for use as assayed external quality controls with in vitro diagnostic assays for the determination of antibodies to HIV-1, antibodies to Hepatitis B core Antigen (anti-HBc), antibodies to Hepatitis C Virus (anti-HCV), and Hepatitis B Surface Antigen (HBsAg).

Assessments and comparisons can be performed using Assayed Virotrol products with the Unity Interlaboratory Program. Unity Real Time, a quality control data management software solution designed to improve the effectiveness of quality control processes, is also available.

Related Links:

Bio-Rad



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer

Latest Immunology News

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
23 Dec 2009  |   Immunology

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
23 Dec 2009  |   Immunology

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
23 Dec 2009  |   Immunology